Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546000 · ClinicalTrials.gov registry record · Phase 4
Cutivate Lotion HPA Axis Pediatric Study
A Phase 4 study, sponsored by Fougera Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT00546000 is a Phase 4 study that has completed, run by Fougera Pharmaceuticals. The registered enrollment target is 56 participants.
The verdict
NCT00546000, a Phase 4 study, has completed, sponsored by Fougera Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
A multi-center, open-label, Phase IV, unblinded study using Cutivate (fluticasone propionate, 0.05%)lotion and it's possible effects on the HPA axis of infants diagnosed with atopic dermatitis.
Interventions
- DRUG Fluticasone propionate 0.05% lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00546000
The ClinicalTrials.gov registry entry for NCT00546000 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fougera Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluticasone propionate 0.05% lotion is the first listed.
NCT00546000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00546000 about?
NCT00546000 is a clinical study titled "Cutivate Lotion HPA Axis Pediatric Study". A multi-center, open-label, Phase IV, unblinded study using Cutivate (fluticasone propionate, 0.05%)lotion and it's possible effects on the HPA axis of infants diagnosed with atopic dermatitis.
What is the current status of trial NCT00546000?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2007-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00546000?
The interventions under investigation include: Fluticasone propionate 0.05% lotion (DRUG).
Who is sponsoring clinical trial NCT00546000?
This trial is sponsored by Fougera Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.